The Whole Brain Activity Map: Merging Nanoscience and Neuroscience for Technology and Health by Yuste, Rafael et al.
THE	  WHOLE	  BRAIN	  ACTIVITY	  MAP:	  
Merging	  Nanoscience	  and	  Neuroscience	  for	  Technology	  and	  Health	  
Nanoscience	  and	  Neuroscience	  are	  at	  a	  crossroads.	  	  Each	  field	  is	  currently	  booming	  in	  its	  own	  right,	  and	  
the	  two	  are	  now	  on	  the	  threshold	  of	  an	  alliance	  that	  will	  mutually	  and	  significantly	  enhance	  one	  
another.	  	  This	  alliance	  will	  provide	  a	  wide	  range	  of	  practical	  benefits.	  
The Ultimate Goal 
The	  ultimate	  goal	  of	  this	  project	  is	  to	  construct	  the	  functional	  connectome	  map	  of	  the	  human	  brain,	  by	  
assembling	  a	  coordinated	  network	  of	  researchers	  deploying	  next-­‐generation	  nanotechnological	  tools	  
with	  unprecedented	  capabilities.	  Mapping	  the	  functional	  connectome	  will	  unravel	  the	  fundamental,	  
long-­‐sought	  paradigms	  of	  how	  the	  brain	  computes.	  Together	  with	  these	  new	  technologies,	  this	  will	  
enable	  accurate	  diagnosing,	  and	  restoring,	  of	  normal	  patterns	  of	  activity	  to	  injured	  or	  diseased	  brains;	  
will	  foster	  the	  development	  of	  broader	  biomedical	  and	  environmental	  applications;	  and	  will	  produce	  a	  
host	  of	  associated	  economic	  benefits.	  
What	  Is	  the	  Functional	  Connectome?	  
The	  connectome	  is	  a	  scientific	  effort	  currently	  under	  way	  that	  will	  give	  us	  a	  detailed	  anatomical	  highway	  
map	  of	  the	  brain.	  	  The	  functional	  connectome,	  that	  we	  are	  proposing,	  will	  make	  that	  map	  
comprehensible	  and	  useful	  by	  telling	  us	  about	  the	  traffic	  on	  those	  highways.	  It	  will	  map	  the	  patterns	  and	  
sequences	  of	  nerve	  cell	  firing	  activity,	  and	  in	  so	  doing,	  reveal	  the	  brain’s	  code.	  	  	  
Why	  We	  Need	  It	  
How	  the	  brain	  makes	  sense	  of	  the	  world	  is	  still	  basically	  unknown.	  One	  major	  reason	  for	  this	  is	  the	  
distinct	  possibility	  that	  the	  neural	  code	  is	  a	  property	  that	  emerges	  from	  widespread	  patterns	  of	  nerve	  
cell	  activity	  in	  many	  parts	  of	  the	  brain	  at	  the	  same	  time.	  	  Current	  imaging	  techniques	  are	  too	  local,	  and	  
either	  too	  slow	  (fMRI)	  or	  too	  blurred	  (electro-­‐	  and	  magneto-­‐encephalography)	  to	  record	  these	  patterns	  
with	  enough	  coverage,	  detail,	  and	  accuracy.	  	  If	  we	  can	  obtain	  higher	  resolution	  data	  over	  the	  entire	  
brain,	  and	  then	  correlate	  the	  recorded	  activities	  with	  their	  anatomical	  circuits	  and	  behavioral	  
consequences,	  we	  would	  be	  in	  a	  position	  to	  decipher	  the	  neuronal	  code,	  and	  to	  understand	  how	  it	  
relates	  to	  behavior.	  
Why	  Now	  
Mapping	  of	  the	  functional	  connectome	  requires	  the	  development	  of	  a	  nanoscale	  analytical	  system	  of	  
unprecedented	  complexity.	  	  Current	  technology	  for	  detecting,	  storing,	  and	  analyzing	  data	  of	  this	  sort	  
exists	  to	  some	  extent	  for	  small	  brains,	  but	  a	  system	  of	  this	  type	  that	  can	  work	  at	  the	  scale	  of	  large	  
animal	  brains,	  or	  even	  human	  brains,	  will	  require	  methods	  and	  technologies	  that	  are	  now	  emerging	  
from	  the	  first	  decade	  of	  the	  National	  Nanotechnology	  Initiative.	  	  Nanosystems	  offer	  the	  only	  feasible	  
way	  forward;	  they	  will	  allow	  for	  comprehensive	  coverage,	  sufficient	  sensitivity,	  and	  minimal	  
invasiveness	  in	  neurophysiological	  research.	  Nanosystems	  comprise	  large	  coherently	  engineered	  
ensembles	  of	  nanodevices	  and	  nanoparticles,	  assembled	  in	  a	  fashion	  yielding	  capabilities	  that	  are	  
immensely	  greater	  than	  the	  sum	  of	  the	  parts.	  	  The	  technological	  capabilities	  for	  producing	  such	  
nanosystems	  en	  masse,	  can	  originate	  by	  leveraging	  the	  immense	  worldwide	  resources	  for	  producing	  
microchips,	  and	  integrating	  these	  with	  bottom	  up	  fabricated	  nanostructures	  that	  can	  report	  on	  local	  
neural	  phenomena	  with	  electrical	  and	  chemical	  specificity.	  	  The	  new	  innovation	  and	  capabilities	  
developed	  in	  the	  course	  of	  this	  project	  will	  provide	  utility	  far	  beyond	  the	  bounds	  of	  this	  project	  and	  
specific	  research	  application.	  	  They	  will	  open	  up	  new	  industrial	  avenues	  for	  our	  nation.	  
Anticipated	  Benefits	  
Easily	  imagined	  benefits	  from	  the	  project	  include	  devices	  and	  techniques	  for	  diagnosing	  brain	  disorders	  
with	  much	  greater	  accuracy	  and	  sensitivity	  than	  are	  currently	  feasible,	  thus	  allowing	  a	  diagnosis	  to	  be	  
made	  earlier	  in	  a	  disease’s	  progress.	  	  Because	  the	  project	  will	  rely	  on	  stimulating	  nerve	  cells	  as	  well	  as	  
monitoring	  their	  activities,	  the	  outcome	  will	  point	  the	  way	  towards	  workable	  strategies	  for	  interventions	  
more	  refined	  and	  longer	  lasting	  than	  those	  currently	  used	  in	  deep-­‐brain	  stimulation	  for	  Parkinson’s	  
disease	  and	  chronic	  depression.	  	  Even	  subtler	  manipulations	  can	  be	  foreseen	  for	  rebalancing	  circuits	  
that	  have	  become	  imbalanced,	  as	  treatments	  for	  schizophrenia	  and	  autism.	  	  	  
On	  the	  engineering	  side,	  the	  nanosystems	  developed	  and	  deployed	  for	  this	  enterprise	  will	  have	  
potential	  uses	  in	  a	  broad	  range	  of	  engineering	  and	  environmental	  applications,	  where	  sensitive,	  
miniature,	  and	  intelligent	  systems	  can	  fulfill	  functions	  that	  are	  currently	  impossible	  with	  existing	  devices.	  	  
This	  project	  realizes	  the	  potential	  for	  merging	  of	  nano-­‐	  and	  bio-­‐technology	  outlined	  several	  years	  ago	  in	  
a	  “Nanotechnology	  White	  Paper”1	  published	  by	  the	  U.S.	  Environmental	  Protection	  Agency,	  which	  stated:	  
The	  convergence	  of	  nanotechnology	  and	  biotechnology	  with	  information	  technology	  and	  cognitive	  
science	  is	  expected	  to	  rapidly	  accelerate	  in	  the	  coming	  decades.	  The	  increased	  understanding	  of	  
biological	  systems	  will	  provide	  valuable	  information	  towards	  the	  development	  of	  efficient	  and	  versatile	  
biomimetic	  tools,	  systems,	  and	  architecture.	  
Non-­‐Obvious	  Economic	  Benefits	  
The	  economic	  activities	  emanating	  from	  this	  project	  are	  likely	  to	  reach	  far	  beyond	  those	  related	  to	  the	  
outcomes	  outlined	  above.	  	  We	  anticipate	  profound	  attendant	  benefits	  such	  as	  occurred	  in	  the	  aftermath	  
of	  the	  Human	  Genome	  Project.	  	  In	  fact,	  there	  are	  numerous	  similarities	  between	  what	  is	  proposed	  here	  
and	  the	  Human	  Genome	  Project:	  it	  is	  a	  comprehensive	  approach	  to	  issues	  that	  had	  previously	  been	  
treated	  piecemeal;	  it	  requires	  concerted	  team	  effort	  (unusual	  for	  basic	  researchers);	  it	  is	  a	  project	  that	  
will	  be	  based	  on	  large-­‐scale	  deployment	  of	  new	  technologies	  and,	  as	  such,	  requires	  formidable	  strategic	  
thinking	  and	  the	  assembly	  of	  substantial	  technological	  resources;	  it	  is	  an	  initiative	  that	  capitalizes	  on	  
emerging	  technologies	  to	  open	  up	  entirely	  new	  realms	  of	  scientific	  inquiry	  and	  economic	  activity;	  and	  it	  
falls	  outside	  of	  the	  current	  funding	  programs	  because	  of	  its	  bridging	  of	  distant	  fields,	  and	  its	  ambitious	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scale.	  	  And	  like	  the	  Human	  Genome	  Project,	  the	  resulting	  economic	  benefits	  are	  likely	  to	  be	  much	  
broader	  and	  greater	  than	  anyone	  imagined,	  and	  perhaps	  will	  be	  realized	  much	  sooner	  than	  anticipated.	  
A	  recent	  report	  from	  the	  Battelle	  Technology	  Partnership	  Practice	  found	  that	  the	  $3.8	  billion	  investment	  
in	  the	  Human	  Genome	  Project	  has	  generated	  $796	  billion	  in	  economic	  impact.2	  The	  economic	  modeling	  
study	  showed	  that	  every	  dollar	  invested	  in	  the	  U.S.	  elements	  of	  the	  project	  generated	  $141	  in	  the	  
economy.	  They	  estimated	  that	  in	  2010	  alone,	  academic	  and	  commercial	  genomic	  sequencing	  and	  
research	  supported	  310,000	  jobs	  and	  generated	  $67	  billion	  in	  economic	  output.	  
This	  exceptional	  return	  on	  investment	  is	  probably	  an	  underestimate,	  since	  the	  major	  anticipated	  
impacts	  of	  the	  Human	  Genome	  Project	  on	  health	  care	  are	  still	  merely	  on	  the	  verge	  of	  realization.	  	  The	  
study’s	  authors	  conclude	  that	  the	  project	  is	  “arguably	  the	  single	  most	  influential	  investment	  to	  have	  
been	  made	  in	  modern	  science.”	  
The	  State	  of	  the	  Art	  
Although	  neuroanatomy	  is	  a	  very	  old	  science,	  connectome	  biology	  is	  relatively	  new.	  	  The	  first	  complete	  
nervous	  system	  wiring	  diagram	  was	  accomplished	  with	  the	  300	  cell	  nervous	  system	  of	  a	  model	  
organism,	  the	  nematode	  in	  the	  1980’s.3	  	  The	  next	  example	  is	  only	  now	  coming	  online	  for	  another	  model	  
organism,	  the	  150,000	  neuron	  brain	  of	  the	  fruit-­‐fly	  Drosophila.4	  	  	  A	  connectome	  project	  for	  the	  mouse	  (4	  
million	  neurons)	  is	  just	  being	  launched5	  with	  an	  anticipated	  completion	  time	  of	  at	  least	  5	  years,	  and	  the	  
prospects	  for	  having	  a	  human	  connectome	  map	  (100	  billion	  neurons)	  is	  decades	  away.6	  	  All	  of	  these	  
efforts	  have	  proceeded	  slowly	  because	  of	  the	  painstaking	  nature	  of	  determining	  the	  shape	  of	  each	  
individual	  nerve	  cell.	  	  Perhaps	  surprisingly,	  the	  technical	  barriers	  to	  obtaining	  the	  functional	  connectome	  
map	  are	  not	  as	  daunting,	  and	  are	  much	  closer	  to	  being	  solved,	  than	  for	  the	  anatomical	  connectome	  
map.	  
Functional	  mapping	  can	  currently	  be	  done	  on	  the	  smallest	  of	  these	  brains,	  the	  nematode	  C.	  elegans	  and	  
the	  fruit	  fly	  Drosophila,	  and	  on	  the	  superficial	  layers	  of	  the	  mouse	  brain,	  but	  the	  sensitivity	  and	  speed	  of	  
the	  recordings	  is	  not	  yet	  adequate.	  	  The	  tools	  are	  proteins	  or	  chemical	  dyes	  that	  fluoresce	  when	  calcium	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levels	  in	  the	  cell	  change,	  a	  technology	  originally	  applied	  to	  nerve	  cell	  recording7	  and	  more	  recently	  
combined	  with	  advances	  in	  microscopy	  to	  enable	  recording	  from	  up	  to	  1,000	  nerve	  cells	  at	  once	  in	  brain	  
tissue	  up	  to	  half	  a	  millimeter	  thick.8	  
The	  technology	  for	  targeted	  stimulation	  of	  nerve	  cells	  has	  existed	  for	  many	  years	  in	  the	  crude	  form	  of	  
implanting	  electrodes	  into	  the	  brain.	  	  More	  recently,	  a	  finer	  grain	  technique	  has	  been	  developed	  that	  
uses	  light-­‐activated	  proteins	  to	  stimulate	  nerve	  cells.9	  
Technology	  has	  been	  demonstrated	  for	  producing	  nanoscale	  probes	  capable	  of	  sensitive	  and	  fast	  
responses	  to	  changes	  in	  voltage.10,11	  	  This	  is	  just	  starting	  to	  be	  exploited	  for	  use	  in	  nerve	  cells,	  but	  
capabilities	  for	  its	  large-­‐scale	  integration	  and	  production	  not	  been	  assembled,	  hence	  its	  subsequent	  
wide	  deployment	  to	  the	  neuroscience	  community	  has	  not	  yet	  become	  possible.	  
Next	  Steps	  
By	  analogy	  to	  the	  role	  played	  by	  C.	  elegans	  and	  Drosophila	  in	  troubleshooting	  and	  laying	  the	  foundations	  
for	  the	  Human	  Genome	  Project,	  these	  model	  systems	  will	  play	  a	  similar	  role	  in	  part	  of	  our	  progression	  
towards	  the	  human	  functional	  connectome.	  On	  this	  front,	  we	  will	  start	  with	  existing	  technology	  (calcium	  
imaging	  and	  state-­‐of-­‐the-­‐art	  microscopy)	  to	  produce	  initial	  functional	  connectome	  maps.	  	  The	  same	  
technology	  will	  be	  used	  on	  a	  piece	  of	  mouse	  brain	  cortex	  (10,000	  cells)	  that	  is	  thin	  enough	  to	  be	  imaged.	  	  
A	  key	  element	  in	  our	  strategy,	  which	  will	  permit	  us	  to	  determine	  the	  input	  and	  output	  for	  each	  nerve	  
cell,	  is	  the	  ability	  to	  stimulate	  in	  a	  targeted	  and	  controlled	  manner.	  	  This	  will	  be	  done	  with	  the	  existing	  
optogenetic	  technology,	  which	  is	  available	  for	  all	  three	  model	  organisms.	  
In	  parallel,	  on	  a	  second	  front,	  we	  will	  develop	  and	  deploy	  a	  new	  generation	  of	  integrated	  nanoscale	  
probes	  that	  combine	  integrated	  electrophysiological	  and	  photonic	  technologies.	  We	  will	  also	  pursue	  
development	  of	  new	  classes	  of	  nanoparticles	  permitting	  optically	  based	  neurophysiological	  stimulation	  
and	  recording	  from	  local,	  very	  selectively	  targeted	  regions	  of	  neuronal	  tissue.	  	  Together	  these	  
nanotechnologies	  will	  enable	  simultaneous	  observation	  and	  stimulation	  across	  deep,	  vast,	  and	  
previously-­‐inaccessible	  regions	  in	  the	  brain,	  and	  thus	  enable	  the	  construction	  of	  a	  full	  functional	  
connectome	  map.	  We	  will	  strategically	  assemble	  resources	  to	  enable	  robust	  mass-­‐production	  of	  systems	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that	  utilize	  these	  tools	  in	  a	  highly	  reproducible	  manner,	  multiplexing	  them	  at	  unprecedented	  scale,	  and	  
deploying	  them	  to	  newly-­‐assembled	  networks	  of	  researchers	  who	  will	  become	  capable	  of	  mapping	  the	  
functional	  connectome.	  	  
The	  Way	  Forward	  
Perfecting	  the	  technological	  capabilities,	  mass-­‐producing	  the	  requisite	  nanosystems,	  and	  assembling	  the	  
collaborative	  research	  networks	  that	  will	  use	  them	  constitutes	  the	  core	  vision	  for	  the	  primary	  organizing	  
phase	  of	  this	  effort.	  	  The	  initial	  research	  phase	  consists	  of	  producing	  the	  preliminary	  functional	  maps	  in	  
model	  systems,	  outlined	  above.	  Beyond	  these	  immediate	  next	  steps,	  we	  envision	  working	  towards	  the	  
ultimate	  development	  of	  subsequent	  generations	  of	  untethered,	  nanoscale	  neural	  probes	  that	  can	  
locally	  acquire,	  process,	  and	  store	  accumulated	  data,	  and	  that	  would	  ultimately	  be	  configurable	  into	  a	  
communications	  network	  within	  the	  tissue.	  	  Such	  device	  networks	  could	  potentially	  address	  the	  long-­‐
standing	  problem	  of	  how	  to	  obtain	  sufficient	  coverage	  in	  deep	  tissue	  layers.	  	  These	  networks	  of	  
“intelligent”	  nanosystems	  would	  also	  be	  capable	  of	  providing	  specific	  responses	  to	  externally	  applied	  
signals,	  or	  to	  their	  own	  readings	  of	  brain	  activity.	  	  Their	  responses	  could	  be	  used	  to	  trigger	  nerve	  cell	  
activity	  in	  a	  measured	  manner,	  and	  could	  comprise	  the	  first	  steps	  in	  controlled	  restoration	  of	  normal	  
patterns	  of	  activity	  in	  damaged	  brains.	  	  This	  would	  initially	  be	  done	  in	  animal	  models	  for	  brain	  injuries,	  
such	  as	  TBI	  and	  PTSD,	  or	  for	  psychiatric	  disease.	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